These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 33733259)
1. Metformin use in patients with type 2 diabetes mellitus and chronic kidney disease: An evidence-based review. Tan FCJH; Ang SB; Bee YM Ann Acad Med Singap; 2021 Feb; 50(2):159-170. PubMed ID: 33733259 [TBL] [Abstract][Full Text] [Related]
2. Metformin: time to review its role and safety in chronic kidney disease. Tanner C; Wang G; Liu N; Andrikopoulos S; Zajac JD; Ekinci EI Med J Aust; 2019 Jul; 211(1):37-42. PubMed ID: 31187887 [TBL] [Abstract][Full Text] [Related]
3. Metformin Use and Risk of All-Cause Mortality and Cardiovascular Events in Patients With Chronic Kidney Disease-A Systematic Review and Meta-Analysis. Hu Y; Lei M; Ke G; Huang X; Peng X; Zhong L; Fu P Front Endocrinol (Lausanne); 2020; 11():559446. PubMed ID: 33117278 [TBL] [Abstract][Full Text] [Related]
4. Appropriateness of metformin prescription for type 2 diabetes mellitus patients with chronic kidney disease (Stages 3-5). Ramachandran M; Loi B; Mat Ariff N; Ng OC; Zahari Sham SY; Thambiah SC; Samsudin IN Malays J Pathol; 2020 Apr; 42(1):71-76. PubMed ID: 32342933 [TBL] [Abstract][Full Text] [Related]
5. Metformin in chronic kidney disease: time for a rethink. Heaf J Perit Dial Int; 2014 Jun; 34(4):353-7. PubMed ID: 24711640 [TBL] [Abstract][Full Text] [Related]
6. The Long-term Effects of Metformin on Patients With Type 2 Diabetic Kidney Disease. Kwon S; Kim YC; Park JY; Lee J; An JN; Kim CT; Oh S; Park S; Kim DK; Oh YK; Kim YS; Lim CS; Lee JP Diabetes Care; 2020 May; 43(5):948-955. PubMed ID: 32132005 [TBL] [Abstract][Full Text] [Related]
7. Metformin use and cardiovascular events in patients with type 2 diabetes and chronic kidney disease. Charytan DM; Solomon SD; Ivanovich P; Remuzzi G; Cooper ME; McGill JB; Parving HH; Parfrey P; Singh AK; Burdmann EA; Levey AS; Eckardt KU; McMurray JJV; Weinrauch LA; Liu J; Claggett B; Lewis EF; Pfeffer MA Diabetes Obes Metab; 2019 May; 21(5):1199-1208. PubMed ID: 30672083 [TBL] [Abstract][Full Text] [Related]
8. Unleash metformin: reconsideration of the contraindication in patients with renal impairment. Lu WR; Defilippi J; Braun A Ann Pharmacother; 2013 Nov; 47(11):1488-97. PubMed ID: 24259604 [TBL] [Abstract][Full Text] [Related]
9. Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus. Hemmingsen B; Sonne DP; Metzendorf MI; Richter B Cochrane Database Syst Rev; 2016 Oct; 10(10):CD012151. PubMed ID: 27749986 [TBL] [Abstract][Full Text] [Related]
10. The Association between Metformin Therapy and Lactic Acidosis. Kuan IHS; Savage RL; Duffull SB; Walker RJ; Wright DFB Drug Saf; 2019 Dec; 42(12):1449-1469. PubMed ID: 31372935 [TBL] [Abstract][Full Text] [Related]
11. Clinical Outcomes of Metformin Use in Populations With Chronic Kidney Disease, Congestive Heart Failure, or Chronic Liver Disease: A Systematic Review. Crowley MJ; Diamantidis CJ; McDuffie JR; Cameron CB; Stanifer JW; Mock CK; Wang X; Tang S; Nagi A; Kosinski AS; Williams JW Ann Intern Med; 2017 Feb; 166(3):191-200. PubMed ID: 28055049 [TBL] [Abstract][Full Text] [Related]
12. Lactic acidosis incidence with metformin in patients with type 2 diabetes and chronic kidney disease: A retrospective nested case-control study. Alvarez CA; Halm EA; Pugh MJV; McGuire DK; Hennessy S; Miller RT; Lingvay I; Vouri SM; Zullo AR; Yang H; Chansard M; Mortensen EM Endocrinol Diabetes Metab; 2021 Jan; 4(1):e00170. PubMed ID: 33532612 [TBL] [Abstract][Full Text] [Related]
13. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Salpeter S; Greyber E; Pasternak G; Salpeter E Cochrane Database Syst Rev; 2003; (2):CD002967. PubMed ID: 12804446 [TBL] [Abstract][Full Text] [Related]
14. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Salpeter S; Greyber E; Pasternak G; Salpeter E Cochrane Database Syst Rev; 2002; (2):CD002967. PubMed ID: 12076461 [TBL] [Abstract][Full Text] [Related]
15. Lactic acidosis due to metformin in type 2 diabetes mellitus and chronic kidney disease stage 3-5: is it significant? Prabhu RA; Mareddy AS; Nagaraju SP; Rangaswamy D; Guddattu V Int Urol Nephrol; 2019 Jul; 51(7):1229-1230. PubMed ID: 30963454 [TBL] [Abstract][Full Text] [Related]
16. Is the use of metformin in patients undergoing dialysis hazardous for life? A systematic review of the safety of metformin in patients undergoing dialysis. Abdel Shaheed C; Carland JE; Graham GG; Stocker SL; Smith G; Hicks M; Williams KM; Furlong T; Macdonald P; Greenfield JR; Smith FC; Chowdhury G; Day RO Br J Clin Pharmacol; 2019 Dec; 85(12):2772-2783. PubMed ID: 31471973 [TBL] [Abstract][Full Text] [Related]
17. Lactic acidosis associated with metformin in patients with moderate to severe chronic kidney disease: study protocol for a multicenter population-based case-control study using health databases. Pedrós C; Ávila M; Gómez-Lumbreras A; Manríquez M; Morros R; BMC Nephrol; 2019 May; 20(1):193. PubMed ID: 31146690 [TBL] [Abstract][Full Text] [Related]
18. Could metformin be used in patients with diabetes and advanced chronic kidney disease? Chowdhury TA; Srirathan D; Abraham G; Oei EL; Fan SL; McCafferty K; Yaqoob MM Diabetes Obes Metab; 2017 Feb; 19(2):156-161. PubMed ID: 27690331 [TBL] [Abstract][Full Text] [Related]
19. Significance of Metformin Use in Diabetic Kidney Disease. Kawanami D; Takashi Y; Tanabe M Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32545901 [TBL] [Abstract][Full Text] [Related]
20. Effects of continuous use of metformin on cardiovascular outcomes in patients with type 2 diabetes after acute myocardial infarction: A protocol for systematic review and meta-analysis. Shen C; Tan S; Yang J Medicine (Baltimore); 2021 Apr; 100(15):e25353. PubMed ID: 33847633 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]